Company news

Xuanzhu Biopharmaceutical Co., Ltd. Class H (HKEX:2575) news

Xuanzhu Biopharmaceutical Co., Ltd. Class H news releases on 6ix. Latest, Jun 21, 2026: VOLUNTARY ANNOUNCEMENT FIRST PATIENT ENROLLED IN PHASE III CLINICAL…

View Xuanzhu Biopharmaceutical Co., Ltd. Class H →

Press releases & updates

VOLUNTARY ANNOUNCEMENT FIRST PATIENT ENROLLED IN PHASE III CLINICAL TRIAL OF ANAPRAZOLE SODIUM FOR HELICOBACTER PYLORI ERADICATION

June 21, 2026

LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION

June 18, 2026